NEW YORK, NY / ACCESSWIRE / November 9, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
The Honest Company, Inc. (NASDAQ:HNST)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/the-honest-company-inc-loss-submission-form?prid=20986&wire=1
Lead Plaintiff Deadline: November 15, 2021
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Honest common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's May 2021 initial public offering.
Allegations against HNST include that: (1) prior to the Initial Public Offering ("IPO"), the Company's results had been significantly impacted by a multimillion-dollar COVID-19 stock-up for products in the Diapers and Wipes category and Household and Wellness category; (2) at the time of the IPO, the Company was experiencing decelerating demand for such products; (3) as a result, the Company's financial results would likely be adversely impacted; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
On24, Inc. (NYSE:ONTF)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/on24-inc-loss-submission-form?prid=20986&wire=1
Lead Plaintiff Deadline: January 3, 2022
This lawsuit is on behalf of persons and entities who also acquired ON24's shares pursuant and traceable to the Offering issued in connection with the Company's February 2, 2021, initial public offering.
Allegations against ONTF include that: the surge in COVID-19 customers observed in the lead up to the IPO consisted of a significant number that did not fit ON24's traditional customer profile, and, as a result, were significantly less likely to renew their contracts.
Silverback Therapeutics, Inc. (NASDAQ:SBTX)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/silverback-therapeutics-inc-loss-submission-form?prid=20986&wire=1
Lead Plaintiff Deadline: January 4, 2022
This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Silverback common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about December 3, 2020 and/or (b) Silverback securities between December 3, 2020 and September 10, 2021, both dates inclusive.
Allegations against SBTX include that: (i) Silverback's lead product candidate SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers, was less effective than the Company had represented to investors; (ii) accordingly, the Company had overstated SBT6050's commercial and/or clinical prospects; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.
To learn more contact Vincent Wong, Esq. either via email email@example.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com: